The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
Population-based genomic screening is at the forefront of a new approach to disease prevention. Yet the lack of diversity in genome wide association studies and ongoing debates about the appropriate use of racial and ethnic categories in genomics raise key questions about the translation of genomic...
Guardado en:
Autores principales: | Jennifer Elyse James, Leslie Riddle, Barbara Ann Koenig, Galen Joseph |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1007395c3bbf4608a8d7e1839c41bdab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial
por: Jennifer Elyse James, et al.
Publicado: (2021) -
Precision oncology- the future of personalized cancer medicine?
por: Ann M. Bode, et al.
Publicado: (2017) -
Personalized immunotherapy in cancer precision medicine
por: Kazuma Kiyotani, et al.
Publicado: (2021) -
SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
por: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Publicado: (2021) -
Precision medicine: the foundation of future cancer therapeutics
por: Seung Ho Shin, et al.
Publicado: (2017)